• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

J&J reports higher earnings than expected in Q3: 6 notes

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 19, 2021 at 11:12: PM
via Johnson & Johnson reported higher earnings per share and lower revenue in the third quarter than Wall Street expected, according to the company's financial results released Oct. 19.

article source
 




Top Bottom
Back
Quote